Works matching IS 09291903 AND DT 2008 AND VI 15 AND IP 2

Results: 8

Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 94, doi. 10.1038/sj.cgt.7701100

By:

Uchino, J.;
Takayama, K.;
Harada, A.;
Sone, T.;
Harada, T.;
Curiel, D. T.;
Kuroki, M.;
Nakanishi, Y.

Publication type:

Article

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 101, doi. 10.1038/sj.cgt.7701101

By:

Shi, Y.;
Zou, M.;
Baitei, E. Y.;
Alzahrani, A. S.;
Parhar, R. S.;
Al-Makhalafi, Z.;
Al-Mohanna, F. A.

Publication type:

Article

DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 108, doi. 10.1038/sj.cgt.7701106

By:

Curcio, C.;
Khan, A. S.;
Amici, A.;
Spadaro, M.;
Quaglino, E.;
Cavallo, F.;
Forni, G.;
Draghia-Akli, R.

Publication type:

Article

Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAIL.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 61, doi. 10.1038/sj.cgt.7701107

By:

Shashkova, E. V.;
Kuppuswamy, M. N.;
Wold, W. S. M.;
Doronin, K.

Publication type:

Article

Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 73, doi. 10.1038/sj.cgt.7701108

By:

Zhang, X.;
Zhao, P.;
Kennedy, C.;
Chen, K.;
Wiegand, J.;
Washington, G.;
Marrero, L.;
Cui, Y.

Publication type:

Article

Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 85, doi. 10.1038/sj.cgt.7701109

By:

Fensterle, J.;
Bergmann, B.;
Yone, C. L. R. P;
Hotz, C.;
Meyer, S. R.;
Spreng, S.;
Goebel, W.;
Rapp, U. R.;
Gentschev, I.

Publication type:

Article

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 115, doi. 10.1038/sj.cgt.7701110

By:

Chalikonda, S.;
Kivlen, M. H.;
O'Malley, M. E.;
(Eric) Dong, X. D.;
McCart, J. A.;
Gorry, M. C.;
Yin, X.-Y.;
Brown, C. K.;
Zeh III, H. J.;
Guo, Z. S.;
Bartlett, D. L.

Publication type:

Article

Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery.

Published in:

Cancer Gene Therapy, 2008, v. 15, n. 2, p. 126, doi. 10.1038/sj.cgt.7701111

By:

Liu, X.;
Wang, Y.;
Nakamura, K.;
Kubo, A.;
Hnatowich, D. J.

Publication type:

Article